Search Results - "Vogler, Birgit"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels by Kleeberg-Hartmann, Johanna, Vogler, Birgit, Messlinger, Karl

    Published in Journal of headache and pain (13-04-2021)
    “…Background Butterbur root extract with its active ingredients petasin and isopetasin has been used in the prophylactic treatment of migraine for years, while…”
    Get full text
    Journal Article
  2. 2

    CGRP outflow into jugular blood and cerebrospinal fluid and permeance for CGRP of rat dura mater by Risch, Miriam, Vogler, Birgit, Dux, Mária, Messlinger, Karl

    Published in Journal of headache and pain (08-09-2021)
    “…Background Calcitonin gene-related peptide (CGRP) is released from activated meningeal afferent fibres in the cranial dura mater, which likely accompanies…”
    Get full text
    Journal Article
  3. 3

    The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats by Vogler, Birgit, Kuhn, Annette, Mackenzie, Kimberly D, Stratton, Jennifer, Dux, Mária, Messlinger, Karl

    “…Treatment with the anti-CGRP antibody fremanezumab is successful in the prevention of chronic and frequent episodic migraine. In preclinical rat experiments,…”
    Get full text
    Journal Article
  4. 4

    Glycerol Trinitrate Acts Downstream of Calcitonin Gene-Related Peptide in Trigeminal Nociception-Evidence from Rodent Experiments with Anti-CGRP Antibody Fremanezumab by Benedicter, Nicola, Vogler, Birgit, Kuhn, Annette, Schramm, Jana, Mackenzie, Kimberly D, Stratton, Jennifer, Dux, Mária, Messlinger, Karl

    Published in Cells (Basel, Switzerland) (01-04-2024)
    “…Calcitonin gene-related peptide (CGRP) and nitric oxide (NO) have been recognized as important mediators in migraine but their mechanisms of action and…”
    Get full text
    Journal Article
  5. 5

    The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow by Dux, Mária, Vogler, Birgit, Kuhn, Annette, Mackenzie, Kimberly D, Stratton, Jennifer, Messlinger, Karl

    Published in Cells (Basel, Switzerland) (28-05-2022)
    “…Monoclonal antibodies directed against the neuropeptide calcitonin gene-related peptide (CGRP) belong to a new generation of therapeutics that are effective in…”
    Get full text
    Journal Article
  6. 6

    Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab by Benedicter, Nicola, Messlinger, Karl, Vogler, Birgit, Mackenzie, Kimberly D, Stratton, Jennifer, Friedrich, Nadine, Dux, Mária

    Published in Neurology international (29-04-2023)
    “…Migraine pain is frequently accompanied by cranial hyperalgesia and allodynia. Calcitonin gene-related peptide (CGRP) is implicated in migraine pathophysiology…”
    Get full text
    Journal Article
  7. 7

    CGRP measurements in human plasma - a methodological study by Messlinger, Karl, Vogler, Birgit, Kuhn, Annette, Sertel-Nakajima, Julika, Frank, Florian, Broessner, Gregor

    Published in Cephalalgia (01-11-2021)
    “…Calcitonin gene-related peptide plasma levels have frequently been determined as a biomarker for primary headaches. However, published data is often…”
    Get more information
    Journal Article
  8. 8

    Meningeal blood flow is controlled by H2S‐NO crosstalk activating a HNO‐TRPA1‐CGRP signalling pathway by Dux, Mária, Will, Christine, Vogler, Birgit, Filipovic, Milos R, Messlinger, Karl

    Published in British journal of pharmacology (01-02-2016)
    “…Background and Purpose Meningeal blood flow is controlled by CGRP released from trigeminal afferents and NO mainly produced in arterial endothelium. The…”
    Get full text
    Journal Article
  9. 9

    High‐dose phenylephrine increases meningeal blood flow through TRPV1 receptor activation and release of calcitonin gene‐related peptide by Dux, Mária, Babes, Alexandru, Manchen, Jessica, Sertel‐Nakajima, Julika, Vogler, Birgit, Schramm, Jana, Messlinger, Karl

    Published in European journal of pain (01-02-2020)
    “…Background The α1‐adrenoceptor agonist, phenylephrine, is used at high concentrations as a mydriatic agent and for the treatment of nasal congestion. Among its…”
    Get full text
    Journal Article
  10. 10

    Meningeal blood flow is controlled by H 2 S‐NO crosstalk activating a HNO ‐ TRPA 1‐ CGRP signalling pathway by Dux, Mária, Will, Christine, Vogler, Birgit, Filipovic, Milos R, Messlinger, Karl

    Published in British journal of pharmacology (01-02-2016)
    “…Background and Purpose Meningeal blood flow is controlled by CGRP released from trigeminal afferents and NO mainly produced in arterial endothelium. The…”
    Get full text
    Journal Article
  11. 11

    H^sub 2^S-NO-TRPA1-CGRP signalling controls meningeal blood flow by Dux, Maria, Will, Christine, Vogler, Birgit, Filipovic, Milos R, Messlinger, Karl

    Published in Neuropeptides (Edinburgh) (01-10-2017)
    “…Calcitonin gene-related peptide (CGRP) and nitric oxide (NO) released in the dura mater encephali mediate meningeal blood flow elevation possibly linked to the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway by Dux, Mária, Will, Christine, Vogler, Birgit, Filipovic, Milos R, Messlinger, Karl

    Published in British journal of pharmacology (01-02-2016)
    “…Meningeal blood flow is controlled by CGRP released from trigeminal afferents and NO mainly produced in arterial endothelium. The vasodilator effect of NO may…”
    Get full text
    Journal Article